var eventsData = [{"Ticker":"CCE","EffectiveDate":"2017-01-11","Type":"RatingUpgrade","Title":"UBS upgrades CCE to Buy from Neutral. Target Price is $38; previously $35.","DailyReturn":0.031746,"FiveDayReturnAfter":0.045914,"FiveDayReturnBefore":0.004137},{"Ticker":"CCE","EffectiveDate":"2017-01-09","Type":"RatingNeutral","Title":"Barclays initiates coverage on CCE to Overweight.","DailyReturn":0.00094,"FiveDayReturnAfter":0.006867,"FiveDayReturnBefore":0.011024},{"Ticker":"CCE","EffectiveDate":"2016-12-28","Type":"Dividend","Title":"The Firm pays dividend $0.178","DailyReturn":-0.00353,"FiveDayReturnAfter":-0.004484,"FiveDayReturnBefore":-0.015547},{"Ticker":"CCE","EffectiveDate":"2016-12-06","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades CCE to Hold from Buy.","DailyReturn":-0.008864,"FiveDayReturnAfter":0.016948,"FiveDayReturnBefore":-0.057808},{"Ticker":"CCE","EffectiveDate":"2016-11-10","Type":"EarningsRevenueMiss","Title":"Before market open, CCE reports 2016 Q3's earning $0.72 per share and revenue $3255MM. This misses analyst's estimated EPS $0.74, misses estimated revenue $3270MM.","DailyReturn":-0.087536,"FiveDayReturnAfter":-0.097639,"FiveDayReturnBefore":-0.012464},{"Ticker":"CCE","EffectiveDate":"2016-10-20","Type":"RatingNeutral","Title":"Kepler Cheuvreux initiates coverage on CCE to Buy.","DailyReturn":-0.004727,"FiveDayReturnAfter":0.003147,"FiveDayReturnBefore":-0.000786},{"Ticker":"CCE","EffectiveDate":"2016-10-10","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CCE to Neutral from Buy.","DailyReturn":-0.025225,"FiveDayReturnAfter":-0.02291,"FiveDayReturnBefore":-0.026669},{"Ticker":"CCE","EffectiveDate":"2016-09-29","Type":"Dividend","Title":"The Firm pays dividend $0.19","DailyReturn":-0.00332,"FiveDayReturnAfter":-0.003839,"FiveDayReturnBefore":-0.008856},{"Ticker":"CCE","EffectiveDate":"2016-09-22","Type":"EarningsMissRevenueBeat","Title":"Before market open, CCE reports 2016 Q2's earning $0.63 per share and revenue $3218MM. This misses analyst's estimated EPS $0.72, beats estimated revenue $3040MM.","DailyReturn":0.013098,"FiveDayReturnAfter":-0.008856,"FiveDayReturnBefore":0.00126},{"Ticker":"CCE","EffectiveDate":"2016-09-15","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on CCE to Neutral.","DailyReturn":0.00227,"FiveDayReturnAfter":0.00126,"FiveDayReturnBefore":-0.012781},{"Ticker":"CCE","EffectiveDate":"2016-07-19","Type":"RatingUpgrade","Title":"Societe Generale upgrades CCE to Buy from Hold.","DailyReturn":0.013514,"FiveDayReturnAfter":0.028773,"FiveDayReturnBefore":0.036328},{"Ticker":"CCE","EffectiveDate":"2016-06-10","Type":"RatingNeutral","Title":"Deutsche Bank assumes CCE to Buy. Target Price is $47.","DailyReturn":-0.024051,"FiveDayReturnAfter":-0.058648,"FiveDayReturnBefore":0.0},{"Ticker":"CCE","EffectiveDate":"2016-06-01","Type":"RatingNeutral","Title":"Barclays maintains CCE to Equal-Weight. Target Price is $40; previously $54.","DailyReturn":0.011595,"FiveDayReturnAfter":0.020655,"FiveDayReturnBefore":0.074942},{"Ticker":"CCE","EffectiveDate":"2016-06-01","Type":"RatingNeutral","Title":"Bank of America initiates coverage on CCE to Buy.","DailyReturn":0.011595,"FiveDayReturnAfter":0.020655,"FiveDayReturnBefore":0.074942},{"Ticker":"CCE","EffectiveDate":"2016-06-01","Type":"RatingNeutral","Title":"CLSA maintains CCE to Outperform. Target Price is $45; previously $60.","DailyReturn":0.011595,"FiveDayReturnAfter":0.020655,"FiveDayReturnBefore":0.074942},{"Ticker":"CCE","EffectiveDate":"2016-05-31","Type":"Dividend","Title":"The Firm pays dividend $14.5","DailyReturn":0.047503,"FiveDayReturnAfter":0.063524,"FiveDayReturnBefore":0.016628},{"Ticker":"CCE","EffectiveDate":"2016-05-31","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on CCE to Buy.","DailyReturn":0.047503,"FiveDayReturnAfter":0.063524,"FiveDayReturnBefore":0.016628},{"Ticker":"CCE","EffectiveDate":"2016-05-31","Type":"RatingUpgrade","Title":"Evercore ISI Group upgrades CCE to Buy from Hold.","DailyReturn":0.047503,"FiveDayReturnAfter":0.063524,"FiveDayReturnBefore":0.016628},{"Ticker":"CCE","EffectiveDate":"2016-05-16","Type":"Dividend","Title":"The Firm pays dividend $0.3","DailyReturn":0.003807,"FiveDayReturnAfter":-0.035649,"FiveDayReturnBefore":-0.022641},{"Ticker":"CCE","EffectiveDate":"2016-04-28","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCE reports 2016 Q1's earning $0.41 per share and revenue $1517MM. This beats analyst's estimated EPS $0.4, misses estimated revenue $1550MM.","DailyReturn":0.037336,"FiveDayReturnAfter":0.016416,"FiveDayReturnBefore":-0.016607},{"Ticker":"CCE","EffectiveDate":"2016-04-14","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades CCE to Buy from Hold.","DailyReturn":0.009439,"FiveDayReturnAfter":-0.002647,"FiveDayReturnBefore":0.00549},{"Ticker":"CCE","EffectiveDate":"2016-03-02","Type":"Dividend","Title":"The Firm pays dividend $0.3","DailyReturn":-0.005337,"FiveDayReturnAfter":0.004914,"FiveDayReturnBefore":-0.000204},{"Ticker":"CCE","EffectiveDate":"2016-02-05","Type":"RatingUpgrade","Title":"Susquehanna upgrades CCE to Neutral from Negative. Target Price is $43; previously $45.","DailyReturn":0.0,"FiveDayReturnAfter":0.010432,"FiveDayReturnBefore":0.014662},{"Ticker":"CCE","EffectiveDate":"2016-01-25","Type":"RatingNeutral","Title":"Jefferies maintains CCE to Hold. Target Price is $49; previously $52.","DailyReturn":0.006176,"FiveDayReturnAfter":0.023542,"FiveDayReturnBefore":-0.018356},{"Ticker":"CCE","EffectiveDate":"2015-11-18","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":0.01157,"FiveDayReturnAfter":0.01367,"FiveDayReturnBefore":-0.011834},{"Ticker":"CCE","EffectiveDate":"2015-09-02","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":0.017572,"FiveDayReturnAfter":-0.030672,"FiveDayReturnBefore":0.011255},{"Ticker":"CCE","EffectiveDate":"2015-08-13","Type":"RatingUpgrade","Title":"CLSA upgrades CCE to Outperform from Underperform. Target Price is $60; previously $56.","DailyReturn":-0.006816,"FiveDayReturnAfter":-0.005315,"FiveDayReturnBefore":0.018728},{"Ticker":"CCE","EffectiveDate":"2015-08-07","Type":"RatingNeutral","Title":"Citigroup maintains CCE to Neutral. Target Price is $56; previously $48.","DailyReturn":-0.031467,"FiveDayReturnAfter":-0.017573,"FiveDayReturnBefore":0.161231},{"Ticker":"CCE","EffectiveDate":"2015-08-06","Type":"RatingNeutral","Title":"Argus Research downgrades CCE to Sell from Buy.","DailyReturn":0.0299,"FiveDayReturnAfter":0.018728,"FiveDayReturnBefore":0.115182},{"Ticker":"CCE","EffectiveDate":"2015-07-31","Type":"RatingNeutral","Title":"Barclays maintains CCE to Equal-Weight. Target Price is $49; previously $48.","DailyReturn":0.12412,"FiveDayReturnAfter":0.161231,"FiveDayReturnBefore":0.00066},{"Ticker":"CCE","EffectiveDate":"2015-06-03","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":0.004307,"FiveDayReturnAfter":-0.027116,"FiveDayReturnBefore":-0.000001},{"Ticker":"CCE","EffectiveDate":"2015-05-27","Type":"RatingUpgrade","Title":"HSBC upgrades CCE to Buy from Neutral. Target Price is $48; previously $50.","DailyReturn":0.014418,"FiveDayReturnAfter":-0.000001,"FiveDayReturnBefore":-0.047513},{"Ticker":"CCE","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"Susquehanna maintains CCE to Negative. Target Price is $28; previously $33.","DailyReturn":-0.020757,"FiveDayReturnAfter":-0.035207,"FiveDayReturnBefore":0.021857},{"Ticker":"CCE","EffectiveDate":"2015-04-14","Type":"RatingNeutral","Title":"Susquehanna initiates coverage on CCE to Negative. Target Price is $33.","DailyReturn":-0.010188,"FiveDayReturnAfter":-0.001329,"FiveDayReturnBefore":-0.012108},{"Ticker":"CCE","EffectiveDate":"2015-03-04","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":-0.016447,"FiveDayReturnAfter":-0.063369,"FiveDayReturnBefore":0.012061},{"Ticker":"CCE","EffectiveDate":"2015-02-13","Type":"RatingNeutral","Title":"Jefferies maintains CCE to Hold. Target Price is $43; previously $40.","DailyReturn":-0.014882,"FiveDayReturnAfter":0.008084,"FiveDayReturnBefore":0.026504},{"Ticker":"CCE","EffectiveDate":"2015-01-26","Type":"RatingNeutral","Title":"Jefferies maintains CCE to Hold. Target Price is $40; previously $42.","DailyReturn":-0.001153,"FiveDayReturnAfter":-0.029259,"FiveDayReturnBefore":0.025465},{"Ticker":"CCE","EffectiveDate":"2015-01-05","Type":"RatingUpgrade","Title":"Bank of America upgrades CCE to Buy from Neutral. Target Price is $52; previously $50.","DailyReturn":0.007748,"FiveDayReturnAfter":-0.002509,"FiveDayReturnBefore":-0.027425},{"Ticker":"CCE","EffectiveDate":"2014-12-19","Type":"RatingNeutral","Title":"Jefferies maintains CCE to Hold. Target Price is $42; previously $41.","DailyReturn":0.011515,"FiveDayReturnAfter":0.019452,"FiveDayReturnBefore":0.000224},{"Ticker":"CCE","EffectiveDate":"2014-12-11","Type":"RatingNeutral","Title":"Jefferies maintains CCE to Hold. Target Price is $41; previously $42.","DailyReturn":0.012346,"FiveDayReturnAfter":-0.022895,"FiveDayReturnBefore":-0.003651},{"Ticker":"CCE","EffectiveDate":"2014-11-19","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.00438,"FiveDayReturnAfter":0.011232,"FiveDayReturnBefore":0.025066},{"Ticker":"CCE","EffectiveDate":"2014-10-31","Type":"RatingNeutral","Title":"Nomura downgrades CCE to Reduce from Neutral. Target Price is $42.","DailyReturn":0.005101,"FiveDayReturnAfter":-0.00628,"FiveDayReturnBefore":0.021797},{"Ticker":"CCE","EffectiveDate":"2014-10-06","Type":"RatingUpgrade","Title":"Nomura upgrades CCE to Neutral from Reduce. Target Price is $43; previously $39.","DailyReturn":-0.005445,"FiveDayReturnAfter":-0.05935,"FiveDayReturnBefore":-0.026858},{"Ticker":"CCE","EffectiveDate":"2014-09-03","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.018735,"FiveDayReturnAfter":-0.01913,"FiveDayReturnBefore":-0.003382},{"Ticker":"CCE","EffectiveDate":"2014-07-25","Type":"RatingNeutral","Title":"Citigroup maintains CCE to Neutral. Target Price is $53; previously $50.","DailyReturn":-0.015369,"FiveDayReturnAfter":-0.071118,"FiveDayReturnBefore":0.008644},{"Ticker":"CCE","EffectiveDate":"2014-07-25","Type":"RatingNeutral","Title":"UBS maintains CCE to Neutral. Target Price is $52; previously $51.","DailyReturn":-0.015369,"FiveDayReturnAfter":-0.071118,"FiveDayReturnBefore":0.008644},{"Ticker":"CCE","EffectiveDate":"2014-07-25","Type":"RatingNeutral","Title":"JP Morgan maintains CCE to Neutral. Target Price is $53; previously $48.","DailyReturn":-0.015369,"FiveDayReturnAfter":-0.071118,"FiveDayReturnBefore":0.008644},{"Ticker":"CCE","EffectiveDate":"2014-07-16","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCE to Buy. Target Price is $52; previously $50.","DailyReturn":0.00477,"FiveDayReturnAfter":0.004553,"FiveDayReturnBefore":0.012943},{"Ticker":"CCE","EffectiveDate":"2014-06-09","Type":"RatingNeutral","Title":"Jefferies initiates coverage on CCE to Hold. Target Price is $45.","DailyReturn":0.002628,"FiveDayReturnAfter":-0.023937,"FiveDayReturnBefore":0.005928},{"Ticker":"CCE","EffectiveDate":"2014-06-04","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.011669,"FiveDayReturnAfter":-0.003307,"FiveDayReturnBefore":0.008134},{"Ticker":"CCE","EffectiveDate":"2014-05-28","Type":"RatingNeutral","Title":"ISI Group initiates coverage on CCE to Neutral. Target Price is $50.","DailyReturn":0.012141,"FiveDayReturnAfter":0.008134,"FiveDayReturnBefore":-0.032578},{"Ticker":"CCE","EffectiveDate":"2014-04-29","Type":"RatingNeutral","Title":"Nomura downgrades CCE to Reduce from Neutral. Target Price is $41; previously $44.5.","DailyReturn":-0.009354,"FiveDayReturnAfter":0.009095,"FiveDayReturnBefore":0.018441},{"Ticker":"CCE","EffectiveDate":"2014-03-05","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":0.016492,"FiveDayReturnAfter":0.004914,"FiveDayReturnBefore":-0.001065},{"Ticker":"CCE","EffectiveDate":"2014-03-04","Type":"RatingNeutral","Title":"UBS initiates coverage on CCE to Neutral.","DailyReturn":0.010767,"FiveDayReturnAfter":0.018815,"FiveDayReturnBefore":-0.017292},{"Ticker":"CCE","EffectiveDate":"2014-02-14","Type":"RatingNeutral","Title":"HSBC downgrades CCE to Neutral from Overweight. Target Price is $49; previously $47.","DailyReturn":0.004134,"FiveDayReturnAfter":0.029584,"FiveDayReturnBefore":0.039047},{"Ticker":"CCE","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Nomura maintains CCE to Neutral. Target Price is $43.5; previously $42.","DailyReturn":0.017693,"FiveDayReturnAfter":0.028833,"FiveDayReturnBefore":0.035539},{"Ticker":"CCE","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Citigroup maintains CCE to Neutral. Target Price is $45; previously $44.","DailyReturn":0.017693,"FiveDayReturnAfter":0.028833,"FiveDayReturnBefore":0.035539},{"Ticker":"CCE","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCE to Buy. Target Price is $47; previously $45.","DailyReturn":0.017693,"FiveDayReturnAfter":0.028833,"FiveDayReturnBefore":0.035539},{"Ticker":"CCE","EffectiveDate":"2013-11-26","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on CCE to Outperform. Target Price is $49.","DailyReturn":0.011347,"FiveDayReturnAfter":0.025504,"FiveDayReturnBefore":-0.008141},{"Ticker":"CCE","EffectiveDate":"2013-11-20","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":-0.003858,"FiveDayReturnAfter":0.010077,"FiveDayReturnBefore":-0.001439},{"Ticker":"CCE","EffectiveDate":"2013-10-25","Type":"RatingNeutral","Title":"Societe Generale downgrades CCE to Hold from Buy.","DailyReturn":0.018047,"FiveDayReturnAfter":0.031153,"FiveDayReturnBefore":-0.035457},{"Ticker":"CCE","EffectiveDate":"2013-10-08","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCE to Buy. Target Price is $45; previously $40.","DailyReturn":-0.002513,"FiveDayReturnAfter":0.030933,"FiveDayReturnBefore":-0.0105},{"Ticker":"CCE","EffectiveDate":"2013-09-04","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":0.010433,"FiveDayReturnAfter":0.033849,"FiveDayReturnBefore":0.03485},{"Ticker":"CCE","EffectiveDate":"2013-09-03","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CCE to Buy from Neutral. Target Price is $47.","DailyReturn":0.030481,"FiveDayReturnAfter":0.061604,"FiveDayReturnBefore":-0.005068},{"Ticker":"CCE","EffectiveDate":"2013-07-25","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCE reports 2013 Q2's earning $0.77 per share and revenue $2160MM. This beats analyst's estimated EPS $0.76, misses estimated revenue $2220MM.","DailyReturn":0.0184,"FiveDayReturnAfter":0.001067,"FiveDayReturnBefore":0.011534},{"Ticker":"CCE","EffectiveDate":"2013-07-18","Type":"RatingNeutral","Title":"Nomura maintains CCE to Neutral. Target Price is $38; previously $35.","DailyReturn":-0.000809,"FiveDayReturnAfter":0.011534,"FiveDayReturnBefore":0.029844},{"Ticker":"CCE","EffectiveDate":"2013-06-14","Type":"RatingNeutral","Title":"Nomura maintains CCE to Neutral. Target Price is $35; previously $37.","DailyReturn":-0.003309,"FiveDayReturnAfter":-0.047438,"FiveDayReturnBefore":-0.012877},{"Ticker":"CCE","EffectiveDate":"2013-06-05","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":-0.01603,"FiveDayReturnAfter":-0.041177,"FiveDayReturnBefore":-0.011098},{"Ticker":"CCE","EffectiveDate":"2013-05-16","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades CCE to Hold from Buy; previously $40.","DailyReturn":-0.012519,"FiveDayReturnAfter":-0.027981,"FiveDayReturnBefore":0.042272},{"Ticker":"CCE","EffectiveDate":"2013-04-25","Type":"EarningsBeatRevenueMiss","Title":"Before market open, CCE reports 2013 Q1's earning $0.39 per share and revenue $1900MM. This beats analyst's estimated EPS $0.38, misses estimated revenue $1920MM.","DailyReturn":-0.021798,"FiveDayReturnAfter":-0.008208,"FiveDayReturnBefore":0.005191},{"Ticker":"CCE","EffectiveDate":"2013-04-16","Type":"RatingUpgrade","Title":"Societe Generale upgrades CCE to Buy from Hold. Target Price is $42.5; previously $37.","DailyReturn":0.026634,"FiveDayReturnAfter":0.011466,"FiveDayReturnBefore":-0.008204},{"Ticker":"CCE","EffectiveDate":"2013-04-01","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CCE to Neutral from Buy. Target Price is $40.","DailyReturn":-0.014355,"FiveDayReturnAfter":-0.025234,"FiveDayReturnBefore":0.001083},{"Ticker":"CCE","EffectiveDate":"2013-03-06","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":-0.008096,"FiveDayReturnAfter":0.007232,"FiveDayReturnBefore":0.029583},{"Ticker":"CCE","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCE to Buy. Target Price is $40; previously $36.","DailyReturn":0.013459,"FiveDayReturnAfter":0.028233,"FiveDayReturnBefore":0.001434},{"Ticker":"CCE","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"UBS maintains CCE to Buy. Target Price is $39; previously $34.","DailyReturn":0.013459,"FiveDayReturnAfter":0.028233,"FiveDayReturnBefore":0.001434},{"Ticker":"CCE","EffectiveDate":"2013-02-07","Type":"EarningBeat","Title":"Before market open, CCE reports 2012 Q4's earning $0.45 per share and revenue $1920MM. This beats analyst's estimated EPS $0.43, meets estimated revenue $1920MM.","DailyReturn":0.000573,"FiveDayReturnAfter":0.013093,"FiveDayReturnBefore":0.005172},{"Ticker":"CCE","EffectiveDate":"2013-01-18","Type":"RatingNeutral","Title":"Deutsche Bank maintains CCE to Buy. Target Price is $35; previously $33.","DailyReturn":0.003219,"FiveDayReturnAfter":0.009032,"FiveDayReturnBefore":0.030004},{"Ticker":"CCE","EffectiveDate":"2012-11-20","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":0.007014,"FiveDayReturnAfter":0.019187,"FiveDayReturnBefore":-0.013528},{"Ticker":"CCE","EffectiveDate":"2012-11-16","Type":"RatingNeutral","Title":"CLSA downgrades CCE to Underperform from Outperform.","DailyReturn":-0.003362,"FiveDayReturnAfter":0.03253,"FiveDayReturnBefore":-0.011035},{"Ticker":"CCE","EffectiveDate":"2012-10-25","Type":"EarningsRelease","Title":"Before market open, CCE reports 2012 Q3's earning $0.88 per share and revenue $2070MM..","DailyReturn":0.005188,"FiveDayReturnAfter":0.014487,"FiveDayReturnBefore":-0.041289},{"Ticker":"CCE","EffectiveDate":"2012-10-10","Type":"RatingNeutral","Title":"Goldman Sachs maintains CCE to Buy. Target Price is $38; previously $35.","DailyReturn":-0.009736,"FiveDayReturnAfter":0.006887,"FiveDayReturnBefore":0.002514},{"Ticker":"CCE","EffectiveDate":"2012-09-27","Type":"RatingNeutral","Title":"UBS maintains CCE to Buy. Target Price is $34; previously $32.","DailyReturn":0.024631,"FiveDayReturnAfter":0.040231,"FiveDayReturnBefore":-0.030083},{"Ticker":"CCE","EffectiveDate":"2012-09-05","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":0.001011,"FiveDayReturnAfter":0.029564,"FiveDayReturnBefore":-0.001341},{"Ticker":"CCE","EffectiveDate":"2012-07-23","Type":"RatingNeutral","Title":"Citigroup maintains CCE to Neutral. Target Price is $30; previously $33.","DailyReturn":0.025708,"FiveDayReturnAfter":0.101253,"FiveDayReturnBefore":-0.017725},{"Ticker":"CCE","EffectiveDate":"2012-07-23","Type":"RevenueBeat","Title":"Before market open, CCE reports 2012 Q2's earning $0.73 per share and revenue $2208MM. This meets analyst's estimated EPS $0.73, misses estimated revenue $2270MM.","DailyReturn":0.025708,"FiveDayReturnAfter":0.101253,"FiveDayReturnBefore":-0.017725},{"Ticker":"CCE","EffectiveDate":"2012-06-06","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":0.024465,"FiveDayReturnAfter":0.018559,"FiveDayReturnBefore":-0.058298},{"Ticker":"CCE","EffectiveDate":"2012-04-27","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CCE to Buy. Target Price is $33; previously $32.","DailyReturn":-0.000672,"FiveDayReturnAfter":-0.009792,"FiveDayReturnBefore":0.039757},{"Ticker":"CCE","EffectiveDate":"2012-04-26","Type":"EarningsRelease","Title":"Before market open, CCE reports 2012 Q1's earning $0.35 per share and revenue $1868MM..","DailyReturn":0.021627,"FiveDayReturnAfter":0.016681,"FiveDayReturnBefore":0.023619},{"Ticker":"CCE","EffectiveDate":"2012-03-07","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":0.016987,"FiveDayReturnAfter":0.027679,"FiveDayReturnBefore":-0.036407}];